Welcome to the community hub built on top of the HDAC6 Wikipedia article.
Here, you can discuss, collect, and organize anything related to HDAC6. The
purpose of the hub is to connect people, foster deeper...
Histone deacetylase 6 is an enzyme that in humans is encoded by the HDAC6gene.[5][6] HDAC6 has emerged as a highly promising candidate to selectively inhibit as a therapeutic strategy to combat several types of cancer and neurodegenerative disorders.[7]
Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromatin structure and affects transcription. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains that appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription.[8]
It retracts the cilium of the cell, which is necessary prior to mitosis.
[9]
HDAC6 affects transcription and translation by regulating heat-shock protein 90 (Hsp90).
HDAC6 is required in the formation of stress granule (SG) proteins and is instrumental in SG formation; pharmacological inhibition or genetic removal of HDAC6 abolished SG formation.[11]
Over expression of this protein correlates with tumorigenesis and cell survival. HDAC6 also encourages metastasis of cancer cells.[11]
Since HDAC6 is dysregulated and/or implicated in several cancers and neurodegenerative disorders, pharmacological inhibition of this specific enzyme holds great therapeutic potential and could also limit side effects associated with pan-inhibitors of multiple HDAC enzymes.[7] Selective inhibition of HDAC6 as a strategy to treat cancers is however also subject of debate, since some HDAC6 inhibitors exhibited anti-tumor activity in vitro and in vivo only when administered in high concentrations, which also produced off-target effects. The findings suggest that further study is needed to clarify data on anti-cancer effects of selective HDAC6 inhibitors.[16]
Mahlknecht U, Schnittger S, Landgraf F, Schoch C, Ottmann OG, Hiddemann W, Hoelzer D (2001). "Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11.23 by in situ hybridization". Cytogenetics and Cell Genetics. 93 (1–2): 135–136. doi:10.1159/000056967. PMID11474198. S2CID41821644.
Voelter-Mahlknecht S, Mahlknecht U (July 2003). "Cloning and structural characterization of the human histone deacetylase 6 gene". International Journal of Molecular Medicine. 12 (1): 87–93. doi:10.3892/ijmm.12.1.87. PMID12792815.
Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, et al. (June 2007). "HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS". Nature. 447 (7146): 859–863. Bibcode:2007Natur.447..860P. doi:10.1038/nature05853. PMID17568747. S2CID4365061.